Index by author

01 January 2009; volume 33, issue 1

A

  1. Achouh, L.

    1. Montani, D. et al "Pulmonary veno-occlusive disease." European Respiratory Journal 33.1 (2009): 189-200. Web. 19 Oct. 2019.

  2. Agamy, G.

    1. Mohamed, S. et al "Nuclear survivin in pN2 nonsmall cell lung cancer: prognostic and clinical implications." European Respiratory Journal 33.1 (2009): 127-133. Web. 19 Oct. 2019.

  3. Agusti, C.

    1. Luna, C. M. et al "Animal models of ventilator-associated pneumonia." European Respiratory Journal 33.1 (2009): 182-188. Web. 19 Oct. 2019.

  4. Albuquerque, A. L. P.

    1. Aliverti, A. et al "Paradoxical movement of the lower ribcage at rest and during exercise in COPD patients." European Respiratory Journal 33.1 (2009): 49-60. Web. 19 Oct. 2019.

  5. Alcaide, F.

    1. Santin, M. et al "Long-term relapses after 12-month treatment for Mycobacterium kansasii lung disease." European Respiratory Journal 33.1 (2009): 148-152. Web. 19 Oct. 2019.

  6. Aliberti, S.

    1. Aliberti, S. et al "The role of neutropenia on outcomes of cancer patients with community-acquired pneumonia." European Respiratory Journal 33.1 (2009): 142-147. Web. 19 Oct. 2019.

  7. Aliverti, A.

    1. Aliverti, A. et al "Paradoxical movement of the lower ribcage at rest and during exercise in COPD patients." European Respiratory Journal 33.1 (2009): 49-60. Web. 19 Oct. 2019.

  8. Anzueto, A.

    1. Restrepo, M. I. et al "Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia." European Respiratory Journal 33.1 (2009): 153-159. Web. 19 Oct. 2019.

  9. Applegate, K.

    1. Llapur, C. J. et al "Lung structure and function of infants with recurrent wheeze when asymptomatic." European Respiratory Journal 33.1 (2009): 107-112. Web. 19 Oct. 2019.

  10. Aubertin, G.

    1. Fauroux, B. et al "Sniff nasal inspiratory pressure in children with muscular, chest wall or lung disease." European Respiratory Journal 33.1 (2009): 113-117. Web. 19 Oct. 2019.

  11. Azoulay, É.

    1. Azoulay, É.. "Pulmonary infiltrates in patients with malignancies: why and how neutropenia influences clinical reasoning." European Respiratory Journal 33.1 (2009): 6-8. Web. 19 Oct. 2019.

B

  1. Beasley, R.

    1. Beasley, R. et al "Safety of long-acting β-agonists: urgent need to clear the air remains." European Respiratory Journal 33.1 (2009): 3-5. Web. 19 Oct. 2019.

  2. Beguin, Y.

    1. Willems, E. et al "Pulmonary veno-occlusive disease in myeloproliferative disorder." European Respiratory Journal 33.1 (2009): 213-216. Web. 19 Oct. 2019.

  3. Bhuniya, S.

    1. Bhuniya, S.. "Pre-immigration screening for pulmonary tuberculosis: the unanswered questions." European Respiratory Journal 33.1 (2009): 221-222. Web. 19 Oct. 2019.

  4. Blasi, F.

    1. Aliberti, S. et al "The role of neutropenia on outcomes of cancer patients with community-acquired pneumonia." European Respiratory Journal 33.1 (2009): 142-147. Web. 19 Oct. 2019.

  5. Boutron-Ruault, M. C.

    1. Varraso, R. et al "Dietary patterns and asthma in the E3N study." European Respiratory Journal 33.1 (2009): 33-41. Web. 19 Oct. 2019.

  6. Bradding, P.

    1. Ohri, C. M. et al "Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survival." European Respiratory Journal 33.1 (2009): 118-126. Web. 19 Oct. 2019.

  7. Brambilla, C.

    1. Brambilla, C.. "From surgical to molecular scalpel: ERJ lung cancer series for 2009." European Respiratory Journal 33.1 (2009): 9-10. Web. 19 Oct. 2019.

  8. Brusasco, V.

    1. Dinh-Xuan, A. T., and V. Brusasco. "The ERJ in its 21st year of age: a smooth transition for an everlasting evolution." European Respiratory Journal 33.1 (2009): 1-2. Web. 19 Oct. 2019.

  9. Bukovskis, M.

    1. Isajevs, S. et al "Decreased FOXP3 expression in small airways of smokers with COPD." European Respiratory Journal 33.1 (2009): 61-67. Web. 19 Oct. 2019.

C

  1. Calverley, P. M.

    1. Aliverti, A. et al "Paradoxical movement of the lower ribcage at rest and during exercise in COPD patients." European Respiratory Journal 33.1 (2009): 49-60. Web. 19 Oct. 2019.

  2. Camara, B.

    1. Degano, B. et al "Long-term effects of bosentan in patients with HIV-associated pulmonary arterial hypertension." European Respiratory Journal 33.1 (2009): 92-98. Web. 19 Oct. 2019.

  3. Canivet, J-L.

    1. Willems, E. et al "Pulmonary veno-occlusive disease in myeloproliferative disorder." European Respiratory Journal 33.1 (2009): 213-216. Web. 19 Oct. 2019.

  4. Casas, S.

    1. Santin, M. et al "Long-term relapses after 12-month treatment for Mycobacterium kansasii lung disease." European Respiratory Journal 33.1 (2009): 148-152. Web. 19 Oct. 2019.

  5. Caviedes, L.

    1. Sheen, P. et al "High MMP-9 activity characterises pleural tuberculosis correlating with granuloma formation." European Respiratory Journal 33.1 (2009): 134-141. Web. 19 Oct. 2019.

  6. Centis, R.

    1. Marica, C. et al "Reversing the tuberculosis upwards trend: a success story in Romania." European Respiratory Journal 33.1 (2009): 168-170. Web. 19 Oct. 2019.

  7. Chakrabarti, B.

    1. Aliverti, A. et al "Paradoxical movement of the lower ribcage at rest and during exercise in COPD patients." European Respiratory Journal 33.1 (2009): 49-60. Web. 19 Oct. 2019.

  8. Chaudhary, K.

    1. Sheen, P. et al "High MMP-9 activity characterises pleural tuberculosis correlating with granuloma formation." European Respiratory Journal 33.1 (2009): 134-141. Web. 19 Oct. 2019.

  9. Chiotan, D.

    1. Marica, C. et al "Reversing the tuberculosis upwards trend: a success story in Romania." European Respiratory Journal 33.1 (2009): 168-170. Web. 19 Oct. 2019.

  10. Chiyo, M.

    1. Mohamed, S. et al "Nuclear survivin in pN2 nonsmall cell lung cancer: prognostic and clinical implications." European Respiratory Journal 33.1 (2009): 127-133. Web. 19 Oct. 2019.

  11. Clavel-Chapelon, F.

    1. Varraso, R. et al "Dietary patterns and asthma in the E3N study." European Respiratory Journal 33.1 (2009): 33-41. Web. 19 Oct. 2019.

  12. Clément, A.

    1. Fauroux, B. et al "Sniff nasal inspiratory pressure in children with muscular, chest wall or lung disease." European Respiratory Journal 33.1 (2009): 113-117. Web. 19 Oct. 2019.

  13. Coalson, J. J.

    1. Restrepo, M. I. et al "Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia." European Respiratory Journal 33.1 (2009): 153-159. Web. 19 Oct. 2019.

  14. Coates, C.

    1. Llapur, C. J. et al "Lung structure and function of infants with recurrent wheeze when asymptomatic." European Respiratory Journal 33.1 (2009): 107-112. Web. 19 Oct. 2019.

  15. Cohen, E.

    1. Fauroux, B. et al "Sniff nasal inspiratory pressure in children with muscular, chest wall or lung disease." European Respiratory Journal 33.1 (2009): 113-117. Web. 19 Oct. 2019.

  16. Colby, T. V.

    1. Park, I. N. et al "Clinical course and lung function change of idiopathic nonspecific interstitial pneumonia." European Respiratory Journal 33.1 (2009): 68-76. Web. 19 Oct. 2019.

  17. Coolen, J.

    1. De Wever, W. et al "Integrated PET/CT in the staging of nonsmall cell lung cancer: technical aspects and clinical integration." European Respiratory Journal 33.1 (2009): 201-212. Web. 19 Oct. 2019.

  18. Cordier, J-F.

    1. Cottin, V. et al "Anti-elastin autoantibodies are not present in combined pulmonary fibrosis and emphysema." European Respiratory Journal 33.1 (2009): 219-221. Web. 19 Oct. 2019.

  19. Cosentini, R.

    1. Aliberti, S. et al "The role of neutropenia on outcomes of cancer patients with community-acquired pneumonia." European Respiratory Journal 33.1 (2009): 142-147. Web. 19 Oct. 2019.

  20. Cottin, V.

    1. Cottin, V. et al "Anti-elastin autoantibodies are not present in combined pulmonary fibrosis and emphysema." European Respiratory Journal 33.1 (2009): 219-221. Web. 19 Oct. 2019.

  21. Coxson, H. O.

    1. Llapur, C. J. et al "Lung structure and function of infants with recurrent wheeze when asymptomatic." European Respiratory Journal 33.1 (2009): 107-112. Web. 19 Oct. 2019.

  22. Crawford, A. B. H.

    1. Dobler, C. C. et al "Recurrence of tuberculosis in a low-incidence setting." European Respiratory Journal 33.1 (2009): 160-167. Web. 19 Oct. 2019.

  23. Crosbie, P. A. J.

    1. Crosbie, P. A. J., and M. A. Woodhead. "Long-term macrolide therapy in chronic inflammatory airway diseases." European Respiratory Journal 33.1 (2009): 171-181. Web. 19 Oct. 2019.

D

  1. D'Ambrosio, L.

    1. Marica, C. et al "Reversing the tuberculosis upwards trend: a success story in Romania." European Respiratory Journal 33.1 (2009): 168-170. Web. 19 Oct. 2019.

  2. Decramer, M.

    1. Troosters, T. et al "Skeletal muscle weakness, exercise tolerance and physical activity in adults with cystic fibrosis." European Respiratory Journal 33.1 (2009): 99-106. Web. 19 Oct. 2019.

  3. Degano, B.

    1. Degano, B. et al "Long-term effects of bosentan in patients with HIV-associated pulmonary arterial hypertension." European Respiratory Journal 33.1 (2009): 92-98. Web. 19 Oct. 2019.

  4. de Leval, L.

    1. Willems, E. et al "Pulmonary veno-occlusive disease in myeloproliferative disorder." European Respiratory Journal 33.1 (2009): 213-216. Web. 19 Oct. 2019.

  5. de Vedia, L.

    1. Aliberti, S. et al "The role of neutropenia on outcomes of cancer patients with community-acquired pneumonia." European Respiratory Journal 33.1 (2009): 142-147. Web. 19 Oct. 2019.

  6. De Wever, W.

    1. De Wever, W. et al "Integrated PET/CT in the staging of nonsmall cell lung cancer: technical aspects and clinical integration." European Respiratory Journal 33.1 (2009): 201-212. Web. 19 Oct. 2019.

  7. Didilescu, C.

    1. Marica, C. et al "Reversing the tuberculosis upwards trend: a success story in Romania." European Respiratory Journal 33.1 (2009): 168-170. Web. 19 Oct. 2019.

  8. Dinh-Xuan, A. T.

    1. Dinh-Xuan, A. T., and V. Brusasco. "The ERJ in its 21st year of age: a smooth transition for an everlasting evolution." European Respiratory Journal 33.1 (2009): 1-2. Web. 19 Oct. 2019.

  9. Ditiu, L.

    1. Marica, C. et al "Reversing the tuberculosis upwards trend: a success story in Romania." European Respiratory Journal 33.1 (2009): 168-170. Web. 19 Oct. 2019.

  10. Djukanovic, R.

    1. Beasley, R. et al "Safety of long-acting β-agonists: urgent need to clear the air remains." European Respiratory Journal 33.1 (2009): 3-5. Web. 19 Oct. 2019.

  11. Do, K-H.

    1. Park, I. N. et al "Clinical course and lung function change of idiopathic nonspecific interstitial pneumonia." European Respiratory Journal 33.1 (2009): 68-76. Web. 19 Oct. 2019.

  12. Dobler, C. C.

    1. Dobler, C. C. et al "Recurrence of tuberculosis in a low-incidence setting." European Respiratory Journal 33.1 (2009): 160-167. Web. 19 Oct. 2019.

  13. Dorca, J.

    1. Santin, M. et al "Long-term relapses after 12-month treatment for Mycobacterium kansasii lung disease." European Respiratory Journal 33.1 (2009): 148-152. Web. 19 Oct. 2019.

  14. Dorfmuller, P.

    1. Montani, D. et al "Pulmonary veno-occlusive disease." European Respiratory Journal 33.1 (2009): 189-200. Web. 19 Oct. 2019.

  15. Dupont, L.

    1. Troosters, T. et al "Skeletal muscle weakness, exercise tolerance and physical activity in adults with cystic fibrosis." European Respiratory Journal 33.1 (2009): 99-106. Web. 19 Oct. 2019.

E

  1. El-Shahhat, H.

    1. Mohamed, S. et al "Nuclear survivin in pN2 nonsmall cell lung cancer: prognostic and clinical implications." European Respiratory Journal 33.1 (2009): 127-133. Web. 19 Oct. 2019.

F

  1. Fabien, N.

    1. Cottin, V. et al "Anti-elastin autoantibodies are not present in combined pulmonary fibrosis and emphysema." European Respiratory Journal 33.1 (2009): 219-221. Web. 19 Oct. 2019.

  2. Fauroux, B.

    1. Fauroux, B. et al "Sniff nasal inspiratory pressure in children with muscular, chest wall or lung disease." European Respiratory Journal 33.1 (2009): 113-117. Web. 19 Oct. 2019.

  3. Friedland, J. S.

    1. Sheen, P. et al "High MMP-9 activity characterises pleural tuberculosis correlating with granuloma formation." European Respiratory Journal 33.1 (2009): 134-141. Web. 19 Oct. 2019.

  4. Fujisawa, T.

    1. Mohamed, S. et al "Nuclear survivin in pN2 nonsmall cell lung cancer: prognostic and clinical implications." European Respiratory Journal 33.1 (2009): 127-133. Web. 19 Oct. 2019.

G

  1. Gaga, M.

    1. Gaga, M.. "Asthma." European Respiratory Journal 33.1 (2009): 225. Web. 19 Oct. 2019.

  2. Galie, N.

    1. Marica, C. et al "Reversing the tuberculosis upwards trend: a success story in Romania." European Respiratory Journal 33.1 (2009): 168-170. Web. 19 Oct. 2019.

  3. Ghaye, B.

    1. Willems, E. et al "Pulmonary veno-occlusive disease in myeloproliferative disorder." European Respiratory Journal 33.1 (2009): 213-216. Web. 19 Oct. 2019.

  4. Gilbert, G. L.

    1. Dobler, C. C. et al "Recurrence of tuberculosis in a low-incidence setting." European Respiratory Journal 33.1 (2009): 160-167. Web. 19 Oct. 2019.

  5. Gilman, R. H.

    1. Sheen, P. et al "High MMP-9 activity characterises pleural tuberculosis correlating with granuloma formation." European Respiratory Journal 33.1 (2009): 134-141. Web. 19 Oct. 2019.

  6. Gonzalez, L.

    1. Santin, M. et al "Long-term relapses after 12-month treatment for Mycobacterium kansasii lung disease." European Respiratory Journal 33.1 (2009): 148-152. Web. 19 Oct. 2019.

  7. Gordjusina, V.

    1. Isajevs, S. et al "Decreased FOXP3 expression in small airways of smokers with COPD." European Respiratory Journal 33.1 (2009): 61-67. Web. 19 Oct. 2019.

  8. Gosselink, R.

    1. Troosters, T. et al "Skeletal muscle weakness, exercise tolerance and physical activity in adults with cystic fibrosis." European Respiratory Journal 33.1 (2009): 99-106. Web. 19 Oct. 2019.

  9. Green, R. H.

    1. Ohri, C. M. et al "Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survival." European Respiratory Journal 33.1 (2009): 118-126. Web. 19 Oct. 2019.

  10. Guerra, M. R.

    1. Santin, M. et al "Long-term relapses after 12-month treatment for Mycobacterium kansasii lung disease." European Respiratory Journal 33.1 (2009): 148-152. Web. 19 Oct. 2019.

H

  1. Hackshaw, A.

    1. Beasley, R. et al "Safety of long-acting β-agonists: urgent need to clear the air remains." European Respiratory Journal 33.1 (2009): 3-5. Web. 19 Oct. 2019.

  2. Hiroshima, K.

    1. Mohamed, S. et al "Nuclear survivin in pN2 nonsmall cell lung cancer: prognostic and clinical implications." European Respiratory Journal 33.1 (2009): 127-133. Web. 19 Oct. 2019.

  3. Hong, X.

    1. Hong, X. et al "Cysteinyl leukotriene receptor 1 gene variation and risk of asthma." European Respiratory Journal 33.1 (2009): 42-48. Web. 19 Oct. 2019.

  4. Humbert, M.

    1. Degano, B. et al "Long-term effects of bosentan in patients with HIV-associated pulmonary arterial hypertension." European Respiratory Journal 33.1 (2009): 92-98. Web. 19 Oct. 2019.
    2. Montani, D. et al "Pulmonary veno-occlusive disease." European Respiratory Journal 33.1 (2009): 189-200. Web. 19 Oct. 2019.

I

  1. Isajevs, S.

    1. Isajevs, S. et al "Decreased FOXP3 expression in small airways of smokers with COPD." European Respiratory Journal 33.1 (2009): 61-67. Web. 19 Oct. 2019.

J

  1. Jaïs, X.

    1. Degano, B. et al "Long-term effects of bosentan in patients with HIV-associated pulmonary arterial hypertension." European Respiratory Journal 33.1 (2009): 92-98. Web. 19 Oct. 2019.
    2. Montani, D. et al "Pulmonary veno-occlusive disease." European Respiratory Journal 33.1 (2009): 189-200. Web. 19 Oct. 2019.

  2. Jang, S. J.

    1. Park, I. N. et al "Clinical course and lung function change of idiopathic nonspecific interstitial pneumonia." European Respiratory Journal 33.1 (2009): 68-76. Web. 19 Oct. 2019.

  3. Janssen, L. J.

    1. Janssen, L. J.. "Asthma therapy: how far have we come, why did we fail and where should we go next?." European Respiratory Journal 33.1 (2009): 11-20. Web. 19 Oct. 2019.

  4. Janssens, W.

    1. Troosters, T. et al "Skeletal muscle weakness, exercise tolerance and physical activity in adults with cystic fibrosis." European Respiratory Journal 33.1 (2009): 99-106. Web. 19 Oct. 2019.

  5. Jegal, Y.

    1. Park, I. N. et al "Clinical course and lung function change of idiopathic nonspecific interstitial pneumonia." European Respiratory Journal 33.1 (2009): 68-76. Web. 19 Oct. 2019.

  6. Jelfs, P. J.

    1. Dobler, C. C. et al "Recurrence of tuberculosis in a low-incidence setting." European Respiratory Journal 33.1 (2009): 160-167. Web. 19 Oct. 2019.

K

  1. Kauffmann, F.

    1. Rage, E. et al "Are asymptomatic airway hyperresponsiveness and allergy risk factors for asthma? A longitudinal study." European Respiratory Journal 33.1 (2009): 218-219. Web. 19 Oct. 2019.
    2. Varraso, R. et al "Dietary patterns and asthma in the E3N study." European Respiratory Journal 33.1 (2009): 33-41. Web. 19 Oct. 2019.

  2. Khouatra, C.

    1. Cottin, V. et al "Anti-elastin autoantibodies are not present in combined pulmonary fibrosis and emphysema." European Respiratory Journal 33.1 (2009): 219-221. Web. 19 Oct. 2019.

  3. Kim, D. S.

    1. Park, I. N. et al "Clinical course and lung function change of idiopathic nonspecific interstitial pneumonia." European Respiratory Journal 33.1 (2009): 68-76. Web. 19 Oct. 2019.

  4. Kim, W. D.

    1. Park, I. N. et al "Clinical course and lung function change of idiopathic nonspecific interstitial pneumonia." European Respiratory Journal 33.1 (2009): 68-76. Web. 19 Oct. 2019.

  5. Kim, W. S.

    1. Park, I. N. et al "Clinical course and lung function change of idiopathic nonspecific interstitial pneumonia." European Respiratory Journal 33.1 (2009): 68-76. Web. 19 Oct. 2019.

  6. Kitaichi, M.

    1. Park, I. N. et al "Clinical course and lung function change of idiopathic nonspecific interstitial pneumonia." European Respiratory Journal 33.1 (2009): 68-76. Web. 19 Oct. 2019.

  7. Koh, Y.

    1. Park, I. N. et al "Clinical course and lung function change of idiopathic nonspecific interstitial pneumonia." European Respiratory Journal 33.1 (2009): 68-76. Web. 19 Oct. 2019.

  8. Kopeika, U.

    1. Isajevs, S. et al "Decreased FOXP3 expression in small airways of smokers with COPD." European Respiratory Journal 33.1 (2009): 61-67. Web. 19 Oct. 2019.

  9. Kratovska, A.

    1. Isajevs, S. et al "Decreased FOXP3 expression in small airways of smokers with COPD." European Respiratory Journal 33.1 (2009): 61-67. Web. 19 Oct. 2019.

L

  1. Langer, D.

    1. Troosters, T. et al "Skeletal muscle weakness, exercise tolerance and physical activity in adults with cystic fibrosis." European Respiratory Journal 33.1 (2009): 99-106. Web. 19 Oct. 2019.

  2. Lee, S. D.

    1. Park, I. N. et al "Clinical course and lung function change of idiopathic nonspecific interstitial pneumonia." European Respiratory Journal 33.1 (2009): 68-76. Web. 19 Oct. 2019.

  3. Le Moual, N.

    1. Rage, E. et al "Are asymptomatic airway hyperresponsiveness and allergy risk factors for asthma? A longitudinal study." European Respiratory Journal 33.1 (2009): 218-219. Web. 19 Oct. 2019.
    2. Varraso, R. et al "Dietary patterns and asthma in the E3N study." European Respiratory Journal 33.1 (2009): 33-41. Web. 19 Oct. 2019.

  4. Le Pavec, J.

    1. Degano, B. et al "Long-term effects of bosentan in patients with HIV-associated pulmonary arterial hypertension." European Respiratory Journal 33.1 (2009): 92-98. Web. 19 Oct. 2019.

  5. Leynaert, B.

    1. Varraso, R. et al "Dietary patterns and asthma in the E3N study." European Respiratory Journal 33.1 (2009): 33-41. Web. 19 Oct. 2019.

  6. Li, X.

    1. Llapur, C. J. et al "Lung structure and function of infants with recurrent wheeze when asymptomatic." European Respiratory Journal 33.1 (2009): 107-112. Web. 19 Oct. 2019.

  7. Lim, C-M.

    1. Park, I. N. et al "Clinical course and lung function change of idiopathic nonspecific interstitial pneumonia." European Respiratory Journal 33.1 (2009): 68-76. Web. 19 Oct. 2019.

  8. Liu, X.

    1. Hong, X. et al "Cysteinyl leukotriene receptor 1 gene variation and risk of asthma." European Respiratory Journal 33.1 (2009): 42-48. Web. 19 Oct. 2019.

  9. Llapur, C. J.

    1. Llapur, C. J. et al "Lung structure and function of infants with recurrent wheeze when asymptomatic." European Respiratory Journal 33.1 (2009): 107-112. Web. 19 Oct. 2019.

  10. Lofaso, F.

    1. Fauroux, B. et al "Sniff nasal inspiratory pressure in children with muscular, chest wall or lung disease." European Respiratory Journal 33.1 (2009): 113-117. Web. 19 Oct. 2019.

  11. Lopardo, G.

    1. Aliberti, S. et al "The role of neutropenia on outcomes of cancer patients with community-acquired pneumonia." European Respiratory Journal 33.1 (2009): 142-147. Web. 19 Oct. 2019.

  12. Lopez, M.

    1. Santin, M. et al "Long-term relapses after 12-month treatment for Mycobacterium kansasii lung disease." European Respiratory Journal 33.1 (2009): 148-152. Web. 19 Oct. 2019.

  13. Luermans, J. G. L. M.

    1. van Gent, M. W. F. et al "Screening for pulmonary arteriovenous malformations using transthoracic contrast echocardiography: a prospective study." European Respiratory Journal 33.1 (2009): 85-91. Web. 19 Oct. 2019.

  14. Luna, C. M.

    1. Luna, C. M. et al "Animal models of ventilator-associated pneumonia." European Respiratory Journal 33.1 (2009): 182-188. Web. 19 Oct. 2019.

M

  1. Mager, J. J.

    1. van Gent, M. W. F. et al "Screening for pulmonary arteriovenous malformations using transthoracic contrast echocardiography: a prospective study." European Respiratory Journal 33.1 (2009): 85-91. Web. 19 Oct. 2019.

  2. Marica, C.

    1. Marica, C. et al "Reversing the tuberculosis upwards trend: a success story in Romania." European Respiratory Journal 33.1 (2009): 168-170. Web. 19 Oct. 2019.

  3. Marks, G. B.

    1. Dobler, C. C. et al "Recurrence of tuberculosis in a low-incidence setting." European Respiratory Journal 33.1 (2009): 160-167. Web. 19 Oct. 2019.

  4. Martinez, F. D.

    1. Beasley, R. et al "Safety of long-acting β-agonists: urgent need to clear the air remains." European Respiratory Journal 33.1 (2009): 3-5. Web. 19 Oct. 2019.

  5. Martínez, T. M.

    1. Llapur, C. J. et al "Lung structure and function of infants with recurrent wheeze when asymptomatic." European Respiratory Journal 33.1 (2009): 107-112. Web. 19 Oct. 2019.

  6. McAuley, D. F.

    1. McKeown, S. et al "MMP expression and abnormal lung permeability are important determinants of outcome in IPF." European Respiratory Journal 33.1 (2009): 77-84. Web. 19 Oct. 2019.

  7. McKeown, S.

    1. McKeown, S. et al "MMP expression and abnormal lung permeability are important determinants of outcome in IPF." European Respiratory Journal 33.1 (2009): 77-84. Web. 19 Oct. 2019.

  8. Menendez, R.

    1. Aliberti, S. et al "The role of neutropenia on outcomes of cancer patients with community-acquired pneumonia." European Respiratory Journal 33.1 (2009): 142-147. Web. 19 Oct. 2019.

  9. Migliori, G. B.

    1. Marica, C. et al "Reversing the tuberculosis upwards trend: a success story in Romania." European Respiratory Journal 33.1 (2009): 168-170. Web. 19 Oct. 2019.

  10. Mohamed, S.

    1. Mohamed, S. et al "Nuclear survivin in pN2 nonsmall cell lung cancer: prognostic and clinical implications." European Respiratory Journal 33.1 (2009): 127-133. Web. 19 Oct. 2019.

  11. Montani, D.

    1. Montani, D. et al "Pulmonary veno-occlusive disease." European Respiratory Journal 33.1 (2009): 189-200. Web. 19 Oct. 2019.

  12. Moreira, A.

    1. Cottin, V. et al "Anti-elastin autoantibodies are not present in combined pulmonary fibrosis and emphysema." European Respiratory Journal 33.1 (2009): 219-221. Web. 19 Oct. 2019.

  13. Mortensen, E. M.

    1. Restrepo, M. I. et al "Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia." European Respiratory Journal 33.1 (2009): 153-159. Web. 19 Oct. 2019.

  14. Musset, D.

    1. Montani, D. et al "Pulmonary veno-occlusive disease." European Respiratory Journal 33.1 (2009): 189-200. Web. 19 Oct. 2019.

  15. Myers, J. A.

    1. Aliberti, S. et al "The role of neutropenia on outcomes of cancer patients with community-acquired pneumonia." European Respiratory Journal 33.1 (2009): 142-147. Web. 19 Oct. 2019.

N

  1. Nakajima, T.

    1. Mohamed, S. et al "Nuclear survivin in pN2 nonsmall cell lung cancer: prognostic and clinical implications." European Respiratory Journal 33.1 (2009): 127-133. Web. 19 Oct. 2019.

  2. Nicholson, A. G.

    1. Park, I. N. et al "Clinical course and lung function change of idiopathic nonspecific interstitial pneumonia." European Respiratory Journal 33.1 (2009): 68-76. Web. 19 Oct. 2019.

O

  1. O'Kane, C.

    1. McKeown, S. et al "MMP expression and abnormal lung permeability are important determinants of outcome in IPF." European Respiratory Journal 33.1 (2009): 77-84. Web. 19 Oct. 2019.

  2. O’Kane, C. M.

    1. Sheen, P. et al "High MMP-9 activity characterises pleural tuberculosis correlating with granuloma formation." European Respiratory Journal 33.1 (2009): 134-141. Web. 19 Oct. 2019.

  3. Ohri, C. M.

    1. Ohri, C. M. et al "Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survival." European Respiratory Journal 33.1 (2009): 118-126. Web. 19 Oct. 2019.

  4. Ottosson, A.

    1. Sears, M. R. et al "Long-acting β-agonists: a review of formoterol safety data from asthma clinical trials." European Respiratory Journal 33.1 (2009): 21-32. Web. 19 Oct. 2019.

  5. Overtoom, T. T.

    1. van Gent, M. W. F. et al "Screening for pulmonary arteriovenous malformations using transthoracic contrast echocardiography: a prospective study." European Respiratory Journal 33.1 (2009): 85-91. Web. 19 Oct. 2019.

P

  1. Park, I. N.

    1. Park, I. N. et al "Clinical course and lung function change of idiopathic nonspecific interstitial pneumonia." European Respiratory Journal 33.1 (2009): 68-76. Web. 19 Oct. 2019.

  2. Peyrani, P.

    1. Aliberti, S. et al "The role of neutropenia on outcomes of cancer patients with community-acquired pneumonia." European Respiratory Journal 33.1 (2009): 142-147. Web. 19 Oct. 2019.

  3. Pin, I.

    1. Rage, E. et al "Are asymptomatic airway hyperresponsiveness and allergy risk factors for asthma? A longitudinal study." European Respiratory Journal 33.1 (2009): 218-219. Web. 19 Oct. 2019.

  4. Plokker, H. W. M.

    1. van Gent, M. W. F. et al "Screening for pulmonary arteriovenous malformations using transthoracic contrast echocardiography: a prospective study." European Respiratory Journal 33.1 (2009): 85-91. Web. 19 Oct. 2019.

  5. Post, M. C.

    1. van Gent, M. W. F. et al "Screening for pulmonary arteriovenous malformations using transthoracic contrast echocardiography: a prospective study." European Respiratory Journal 33.1 (2009): 85-91. Web. 19 Oct. 2019.

  6. Preiser, J-C.

    1. Willems, E. et al "Pulmonary veno-occlusive disease in myeloproliferative disorder." European Respiratory Journal 33.1 (2009): 213-216. Web. 19 Oct. 2019.

  7. Price, L. C.

    1. Montani, D. et al "Pulmonary veno-occlusive disease." European Respiratory Journal 33.1 (2009): 189-200. Web. 19 Oct. 2019.

Q

  1. Quaranta, M.

    1. Aliverti, A. et al "Paradoxical movement of the lower ribcage at rest and during exercise in COPD patients." European Respiratory Journal 33.1 (2009): 49-60. Web. 19 Oct. 2019.

R

  1. Rabe, K. F.

    1. Beasley, R. et al "Safety of long-acting β-agonists: urgent need to clear the air remains." European Respiratory Journal 33.1 (2009): 3-5. Web. 19 Oct. 2019.

  2. Radermecker, M.

    1. Willems, E. et al "Pulmonary veno-occlusive disease in myeloproliferative disorder." European Respiratory Journal 33.1 (2009): 213-216. Web. 19 Oct. 2019.

  3. Radner, F.

    1. Sears, M. R. et al "Long-acting β-agonists: a review of formoterol safety data from asthma clinical trials." European Respiratory Journal 33.1 (2009): 21-32. Web. 19 Oct. 2019.

  4. Rage, E.

    1. Rage, E. et al "Are asymptomatic airway hyperresponsiveness and allergy risk factors for asthma? A longitudinal study." European Respiratory Journal 33.1 (2009): 218-219. Web. 19 Oct. 2019.

  5. Ramirez, J. A.

    1. Aliberti, S. et al "The role of neutropenia on outcomes of cancer patients with community-acquired pneumonia." European Respiratory Journal 33.1 (2009): 142-147. Web. 19 Oct. 2019.

  6. Restrepo, M. I.

    1. Restrepo, M. I. et al "Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia." European Respiratory Journal 33.1 (2009): 153-159. Web. 19 Oct. 2019.

  7. Richter, A. G.

    1. McKeown, S. et al "MMP expression and abnormal lung permeability are important determinants of outcome in IPF." European Respiratory Journal 33.1 (2009): 77-84. Web. 19 Oct. 2019.

  8. Romieu, I.

    1. Varraso, R. et al "Dietary patterns and asthma in the E3N study." European Respiratory Journal 33.1 (2009): 33-41. Web. 19 Oct. 2019.

  9. Rossi, P.

    1. Aliberti, S. et al "The role of neutropenia on outcomes of cancer patients with community-acquired pneumonia." European Respiratory Journal 33.1 (2009): 142-147. Web. 19 Oct. 2019.

S

  1. Said, S. I.

    1. Said, S. I.. "Animal models of airway hyperresponsiveness." European Respiratory Journal 33.1 (2009): 217-218. Web. 19 Oct. 2019.

  2. Santillan, C.

    1. Sheen, P. et al "High MMP-9 activity characterises pleural tuberculosis correlating with granuloma formation." European Respiratory Journal 33.1 (2009): 134-141. Web. 19 Oct. 2019.

  3. Santin, M.

    1. Santin, M. et al "Long-term relapses after 12-month treatment for Mycobacterium kansasii lung disease." European Respiratory Journal 33.1 (2009): 148-152. Web. 19 Oct. 2019.

  4. Savale, L.

    1. Degano, B. et al "Long-term effects of bosentan in patients with HIV-associated pulmonary arterial hypertension." European Respiratory Journal 33.1 (2009): 92-98. Web. 19 Oct. 2019.

  5. Sears, M. R.

    1. Sears, M. R. et al "Long-acting β-agonists: a review of formoterol safety data from asthma clinical trials." European Respiratory Journal 33.1 (2009): 21-32. Web. 19 Oct. 2019.

  6. Segers, J.

    1. Troosters, T. et al "Skeletal muscle weakness, exercise tolerance and physical activity in adults with cystic fibrosis." European Respiratory Journal 33.1 (2009): 99-106. Web. 19 Oct. 2019.

  7. Sekine, Y.

    1. Mohamed, S. et al "Nuclear survivin in pN2 nonsmall cell lung cancer: prognostic and clinical implications." European Respiratory Journal 33.1 (2009): 127-133. Web. 19 Oct. 2019.

  8. Sheen, P.

    1. Sheen, P. et al "High MMP-9 activity characterises pleural tuberculosis correlating with granuloma formation." European Respiratory Journal 33.1 (2009): 134-141. Web. 19 Oct. 2019.

  9. Shibuya, K.

    1. Mohamed, S. et al "Nuclear survivin in pN2 nonsmall cell lung cancer: prognostic and clinical implications." European Respiratory Journal 33.1 (2009): 127-133. Web. 19 Oct. 2019.

  10. Shikotra, A.

    1. Ohri, C. M. et al "Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survival." European Respiratory Journal 33.1 (2009): 118-126. Web. 19 Oct. 2019.

  11. Shim, T. S.

    1. Park, I. N. et al "Clinical course and lung function change of idiopathic nonspecific interstitial pneumonia." European Respiratory Journal 33.1 (2009): 68-76. Web. 19 Oct. 2019.

  12. Sibila, O.

    1. Luna, C. M. et al "Animal models of ventilator-associated pneumonia." European Respiratory Journal 33.1 (2009): 182-188. Web. 19 Oct. 2019.

  13. Simonneau, G.

    1. Degano, B. et al "Long-term effects of bosentan in patients with HIV-associated pulmonary arterial hypertension." European Respiratory Journal 33.1 (2009): 92-98. Web. 19 Oct. 2019.
    2. Montani, D. et al "Pulmonary veno-occlusive disease." European Respiratory Journal 33.1 (2009): 189-200. Web. 19 Oct. 2019.

  14. Siroux, V.

    1. Rage, E. et al "Are asymptomatic airway hyperresponsiveness and allergy risk factors for asthma? A longitudinal study." European Respiratory Journal 33.1 (2009): 218-219. Web. 19 Oct. 2019.

  15. Sitbon, O.

    1. Degano, B. et al "Long-term effects of bosentan in patients with HIV-associated pulmonary arterial hypertension." European Respiratory Journal 33.1 (2009): 92-98. Web. 19 Oct. 2019.
    2. Montani, D. et al "Pulmonary veno-occlusive disease." European Respiratory Journal 33.1 (2009): 189-200. Web. 19 Oct. 2019.

  16. Snijder, R. J.

    1. van Gent, M. W. F. et al "Screening for pulmonary arteriovenous malformations using transthoracic contrast echocardiography: a prospective study." European Respiratory Journal 33.1 (2009): 85-91. Web. 19 Oct. 2019.

  17. Sosa, J.

    1. Sheen, P. et al "High MMP-9 activity characterises pleural tuberculosis correlating with granuloma formation." European Respiratory Journal 33.1 (2009): 134-141. Web. 19 Oct. 2019.

  18. Sotgiu, G.

    1. Marica, C. et al "Reversing the tuberculosis upwards trend: a success story in Romania." European Respiratory Journal 33.1 (2009): 168-170. Web. 19 Oct. 2019.

  19. Stamp, G.

    1. Sheen, P. et al "High MMP-9 activity characterises pleural tuberculosis correlating with granuloma formation." European Respiratory Journal 33.1 (2009): 134-141. Web. 19 Oct. 2019.

  20. Sterk, P. J.

    1. Beasley, R. et al "Safety of long-acting β-agonists: urgent need to clear the air remains." European Respiratory Journal 33.1 (2009): 3-5. Web. 19 Oct. 2019.

  21. Strazda, G.

    1. Isajevs, S. et al "Decreased FOXP3 expression in small airways of smokers with COPD." European Respiratory Journal 33.1 (2009): 61-67. Web. 19 Oct. 2019.

  22. Stroobants, S.

    1. De Wever, W. et al "Integrated PET/CT in the staging of nonsmall cell lung cancer: technical aspects and clinical integration." European Respiratory Journal 33.1 (2009): 201-212. Web. 19 Oct. 2019.

  23. Suissa, S.

    1. Sears, M. R. et al "Long-acting β-agonists: a review of formoterol safety data from asthma clinical trials." European Respiratory Journal 33.1 (2009): 21-32. Web. 19 Oct. 2019.

  24. Suzuki, M.

    1. Mohamed, S. et al "Nuclear survivin in pN2 nonsmall cell lung cancer: prognostic and clinical implications." European Respiratory Journal 33.1 (2009): 127-133. Web. 19 Oct. 2019.

T

  1. Taivans, I.

    1. Isajevs, S. et al "Decreased FOXP3 expression in small airways of smokers with COPD." European Respiratory Journal 33.1 (2009): 61-67. Web. 19 Oct. 2019.

  2. Tepper, R. S.

    1. Llapur, C. J. et al "Lung structure and function of infants with recurrent wheeze when asymptomatic." European Respiratory Journal 33.1 (2009): 107-112. Web. 19 Oct. 2019.

  3. Thickett, D. R.

    1. McKeown, S. et al "MMP expression and abnormal lung permeability are important determinants of outcome in IPF." European Respiratory Journal 33.1 (2009): 77-84. Web. 19 Oct. 2019.

  4. Tiller, C.

    1. Llapur, C. J. et al "Lung structure and function of infants with recurrent wheeze when asymptomatic." European Respiratory Journal 33.1 (2009): 107-112. Web. 19 Oct. 2019.

  5. Torres, A.

    1. Luna, C. M. et al "Animal models of ventilator-associated pneumonia." European Respiratory Journal 33.1 (2009): 182-188. Web. 19 Oct. 2019.

  6. Tovar, M.

    1. Sheen, P. et al "High MMP-9 activity characterises pleural tuberculosis correlating with granuloma formation." European Respiratory Journal 33.1 (2009): 134-141. Web. 19 Oct. 2019.

  7. Troosters, T.

    1. Troosters, T. et al "Skeletal muscle weakness, exercise tolerance and physical activity in adults with cystic fibrosis." European Respiratory Journal 33.1 (2009): 99-106. Web. 19 Oct. 2019.

  8. Tsai, H-J.

    1. Hong, X. et al "Cysteinyl leukotriene receptor 1 gene variation and risk of asthma." European Respiratory Journal 33.1 (2009): 42-48. Web. 19 Oct. 2019.

V

  1. van Gent, M. W. F.

    1. van Gent, M. W. F. et al "Screening for pulmonary arteriovenous malformations using transthoracic contrast echocardiography: a prospective study." European Respiratory Journal 33.1 (2009): 85-91. Web. 19 Oct. 2019.

  2. Varraso, R.

    1. Varraso, R. et al "Dietary patterns and asthma in the E3N study." European Respiratory Journal 33.1 (2009): 33-41. Web. 19 Oct. 2019.

  3. Verschakelen, J. A.

    1. De Wever, W. et al "Integrated PET/CT in the staging of nonsmall cell lung cancer: technical aspects and clinical integration." European Respiratory Journal 33.1 (2009): 201-212. Web. 19 Oct. 2019.

  4. Vrijsen, B.

    1. Troosters, T. et al "Skeletal muscle weakness, exercise tolerance and physical activity in adults with cystic fibrosis." European Respiratory Journal 33.1 (2009): 99-106. Web. 19 Oct. 2019.

W

  1. Waller, D. A.

    1. Ohri, C. M. et al "Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survival." European Respiratory Journal 33.1 (2009): 118-126. Web. 19 Oct. 2019.

  2. Wang, B.

    1. Hong, X. et al "Cysteinyl leukotriene receptor 1 gene variation and risk of asthma." European Respiratory Journal 33.1 (2009): 42-48. Web. 19 Oct. 2019.

  3. Wang, X.

    1. Hong, X. et al "Cysteinyl leukotriene receptor 1 gene variation and risk of asthma." European Respiratory Journal 33.1 (2009): 42-48. Web. 19 Oct. 2019.

  4. Waterer, G. W.

    1. Restrepo, M. I. et al "Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia." European Respiratory Journal 33.1 (2009): 153-159. Web. 19 Oct. 2019.

  5. Westermann, C. J. J.

    1. van Gent, M. W. F. et al "Screening for pulmonary arteriovenous malformations using transthoracic contrast echocardiography: a prospective study." European Respiratory Journal 33.1 (2009): 85-91. Web. 19 Oct. 2019.

  6. Wiebke, J. L.

    1. Llapur, C. J. et al "Lung structure and function of infants with recurrent wheeze when asymptomatic." European Respiratory Journal 33.1 (2009): 107-112. Web. 19 Oct. 2019.

  7. Willems, E.

    1. Willems, E. et al "Pulmonary veno-occlusive disease in myeloproliferative disorder." European Respiratory Journal 33.1 (2009): 213-216. Web. 19 Oct. 2019.

  8. Woodhead, M. A.

    1. Crosbie, P. A. J., and M. A. Woodhead. "Long-term macrolide therapy in chronic inflammatory airway diseases." European Respiratory Journal 33.1 (2009): 171-181. Web. 19 Oct. 2019.

  9. Wouters, K.

    1. Troosters, T. et al "Skeletal muscle weakness, exercise tolerance and physical activity in adults with cystic fibrosis." European Respiratory Journal 33.1 (2009): 99-106. Web. 19 Oct. 2019.

  10. Wunderink, R. G.

    1. Restrepo, M. I. et al "Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia." European Respiratory Journal 33.1 (2009): 153-159. Web. 19 Oct. 2019.

X

  1. Xu, X.

    1. Hong, X. et al "Cysteinyl leukotriene receptor 1 gene variation and risk of asthma." European Respiratory Journal 33.1 (2009): 42-48. Web. 19 Oct. 2019.
    2. Hong, X. et al "Cysteinyl leukotriene receptor 1 gene variation and risk of asthma." European Respiratory Journal 33.1 (2009): 42-48. Web. 19 Oct. 2019.

Y

  1. Yaïci, A.

    1. Degano, B. et al "Long-term effects of bosentan in patients with HIV-associated pulmonary arterial hypertension." European Respiratory Journal 33.1 (2009): 92-98. Web. 19 Oct. 2019.
    2. Montani, D. et al "Pulmonary veno-occlusive disease." European Respiratory Journal 33.1 (2009): 189-200. Web. 19 Oct. 2019.

  2. Yasufuku, K.

    1. Mohamed, S. et al "Nuclear survivin in pN2 nonsmall cell lung cancer: prognostic and clinical implications." European Respiratory Journal 33.1 (2009): 127-133. Web. 19 Oct. 2019.

  3. Yoo, B.

    1. Park, I. N. et al "Clinical course and lung function change of idiopathic nonspecific interstitial pneumonia." European Respiratory Journal 33.1 (2009): 68-76. Web. 19 Oct. 2019.

  4. Yoshida, S.

    1. Mohamed, S. et al "Nuclear survivin in pN2 nonsmall cell lung cancer: prognostic and clinical implications." European Respiratory Journal 33.1 (2009): 127-133. Web. 19 Oct. 2019.

  5. Yoshino, I.

    1. Mohamed, S. et al "Nuclear survivin in pN2 nonsmall cell lung cancer: prognostic and clinical implications." European Respiratory Journal 33.1 (2009): 127-133. Web. 19 Oct. 2019.

Z

  1. Zellweger, J. P.

    1. Marica, C. et al "Reversing the tuberculosis upwards trend: a success story in Romania." European Respiratory Journal 33.1 (2009): 168-170. Web. 19 Oct. 2019.

  2. Zhou, H.

    1. Hong, X. et al "Cysteinyl leukotriene receptor 1 gene variation and risk of asthma." European Respiratory Journal 33.1 (2009): 42-48. Web. 19 Oct. 2019.
Back to top
European Respiratory Journal: 33 (1)

Search Within This Issue

Jump to

Manage Table of content Alerts